FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.
The five-year federal grant will fund research into N-acetylcysteine and cognitive therapy for 160 young patients with mild depression who aren't taking medications.
Tucson has quietly become one of the more thoughtful cities in the Southwest when it comes to community-based mental health support. If you have ever wondered whether local businesses in ...
When a teenager is struggling, parents often feel caught between urgency and uncertainty. They know something is wrong, but they are not always sure where to turn, how serious things ...
Reopened Allentown facility expands addiction treatment capacity and launches specialized reentry track Strong ...
But for two hours on a Friday morning, in a small art room, the mood shifts. A garden therapy program, run in partnership with the Acton Garden Club and Trader Joe’s, brings a splash of color and a ...
For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS)—a ...
A well-designed new study suggests that the keto diet may modestly alleviate symptoms for people with treatment-resistant depression. The keto diet is high in healthy fats and low in carbohydrates. It ...
A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international collaborators highlights a new approach to treating depression that bypasses many ...
Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel better—and stay better—for at least two years. Most participants had lived ...
For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker Neurolief announced on Tuesday. ProlivRx is the first home-based ...